RecruitingNCT04633655

International CIPN Assessment and Validation Study

International Chemotherapy Induced Peripheral Neurotoxicity (CIPN) Assessment and Validation Study

Sponsor

University of Milano Bicocca

Enrollment

1,000 participants

Start Date

Jun 8, 2020

Study Type

OBSERVATIONAL

Conditions

Chemotherapy Induced Peripheral Neuropathy Quality of Life

Summary

This is an observational study of chemotherapy-induced peripheral neurotoxicity (CIPN) patients to be investigated prospectively in order to assess responsiveness of a set of outcome measures in an international multi-center study.

Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying outcome measures for CIPN testing for people with chemotherapy induced peripheral neuropathy and quality of life. The study is currently recruiting participants at 30 locations. People eligible for this study include aged 18 Years and older.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

OTHERoutcome measures for CIPN testing

questionnaires administration, physician based scales for CIPN data collection

Locations(30)

Birmingham School of Nursing, University of Alabama

Birmingham, Alabama, United States

Northside Hospital

Atlanta, Georgia, United States

JHU

Baltimore, Maryland, United States

University of Michigan School of Nursing

Ann Arbor, Michigan, United States

Columbia University Irving Medical Center

New York, New York, United States

Cancer Center/Wexner Medical Center - Ohio State Medical Oncology Division

Columbus, Ohio, United States

Dartmouth-Hitchcock Medical Center

Lebanon, Pennsylvania, United States

University of Vermont Medical Center

Burlington, Vermont, United States

Brain and Mind Center

Sydney, Australia

Dept. of Neurology, Medical University of Vienna

Vienna, Austria

International Centre for Diarrhoeal Disease Research

Dhaka, Bangladesh

Clínica AMO

Salvador, Brazil

The Ottawa Hospital

Ottawa, Canada

Aarhus University Hospital

Aarhus, Denmark

Hôpital Percy

Clamart, France

CHU Dupuytren

Limoges, France

Center for Molecular Medicine

Cologne, Germany

University of Larissa

Larissa, Greece

"Saint Andrew's" State General Hospital

Pátrai, Greece

San Gerardo Hospital

Monza, Mb, Italy

Ospedale Valduce

Como, Italy

Ospedale Policlinico San Martino

Genova, Italy

A.O.U. Policlinico "G. Martino"

Messina, Italy

Padova Hospital

Padova, Italy

Azienda Ospedaliera Universitaria

Verona, Italy

Medical Oncoloy Unit - University of Nairobi

Nairobi, Kenya

Centro Hospitalar Vila Nova de Gaia/Espinho

Vila Nova de Gaia, Portugal

Dong-A University - Internal Medicine Dept.

Busan, South Korea

Hospital Universitari de Bellvitge-ICO L'Hospitalet

Barcelona, Spain

University of Basel - Department of Sport, Exercise and Health

Basel, Switzerland

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT04633655

Related Trials

Generation Victoria Cohort 2020s: A Statewide Longitudinal Cohort Study of Victorian Children and Their Parents

NCT053943631 location

Stereotactic Radiosurgery for Essential Tremor and Parkinsonian Tremor

NCT017341221 location

Effect of Alcohol Sclerotherapy on Pelvic Pain and Quality of Life in Women With Ovarian Endometriosis

NCT0695522128 locations

Quality of Life Questionnaire in Pulmonary Hypertension EMPHASIS-10: Brazilian Adaptation and Validation

NCT07822997

Guaraná Supplementation for Cancer-Related Fatigue

NCT07816263